Sanofi Is Looking at US Biotech Acquisitions -Bloomberg
17 Julho 2020 - 3:29AM
Dow Jones News
--Sanofi SA is looking at potential U.S. biotech acquisitions as
it seeks to expand its work in multiple sclerosis and immune
disorders, Bloomberg reports, citing unnamed sources.
--One of the targets being studied by the French company is
Pricipia Biopharma Inc., Bloomberg reports.
Full story: https://bloom.bg/2CF0OYj
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
July 17, 2020 02:14 ET (06:14 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Sanofi (EU:SAN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024